84 results
Page 3 of 5
8-K
EX-4.1
ke4nr4vy
4 Feb 21
Equillium Announces Pricing of $30 Million Registered Direct Offering
8:10am
424B5
70fn 2kzbpp8u
4 Feb 21
Prospectus supplement for primary offering
8:07am
424B5
umkjg
14 Aug 20
Prospectus supplement for primary offering
4:45pm
424B5
l5nlrwry
13 Aug 20
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
r7o i2q00726
10 Aug 20
Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
5:21pm
424B5
x5hc2pd
14 Jul 20
Prospectus supplement for primary offering
6:05am
8-K
EX-10.1
m2jqz xbgn
30 Mar 20
Entry into a Material Definitive Agreement
4:15pm
S-3
f61bobdzd vw
13 Nov 19
Shelf registration
5:20pm
S-3
EX-4.4
s1ynf
13 Nov 19
Shelf registration
5:20pm
8-K
EX-99.2
ps3 fhbc5l
1 Oct 19
Entry into a Material Definitive Agreement
4:10pm